ABP Pediatric Hematology-Oncology flashcards
ABP Pediatric Hematology-Oncology · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Mentzer index
- MCV divided by RBC count; a value below 13 favors thalassemia trait, whereas a value above 13 favors iron deficiency, though pediatric age and other conditions limit accuracy.
- Iron deficiency treatment
- Oral elemental iron is commonly dosed at 3–6 mg/kg/day; continue several months after hemoglobin normalizes to replenish stores. Transfuse only for severe symptomatic anemia.
- Warm autoimmune hemolytic anemia
- Immune hemolysis with a positive DAT for IgG; first-line therapy is corticosteroids, and transfusion is given for symptomatic anemia using the least incompatible units rather than withheld absolutely.
- Hydroxyurea in sickle cell
- Daily hydroxyurea reduces painful episodes, acute chest syndrome, and transfusions in sickle cell disease; monitor CBC and adherence, and counsel about reversible myelosuppression and potential fertility effects.
- Beta thalassemia major
- Transfusion-dependent anemia from absent beta-globin production; chronic transfusions suppress ineffective erythropoiesis but require iron chelation, monitoring ferritin and organ iron, plus splenectomy only for specific indications.
- Fanconi anemia
- Inherited bone marrow failure with progressive pancytopenia, congenital anomalies, and cancer predisposition; diagnosis uses chromosome breakage testing, and care includes androgen, transplant, and cancer surveillance.
- Diamond-Blackfan anemia
- Pure red cell aplasia presenting in infancy with anemia, reticulocytopenia, and often congenital anomalies; corticosteroids are first-line, and transfusion with iron chelation supports nonresponders.
- Hemophilia severity
- Severity reflects factor activity: severe is below 1%, moderate 1–5%, and mild above 5%; severe disease causes spontaneous hemarthroses, while mild disease bleeds mainly after trauma or surgery.
- von Willebrand disease
- Mucocutaneous bleeding from quantitative or qualitative von Willebrand factor defects; desmopressin helps type 1, while factor concentrate is needed for severe or type 3 disease.
- Immune thrombocytopenia
- Isolated thrombocytopenia from platelet autoantibodies, diagnosed after excluding other causes; treat with IVIG or corticosteroids when bleeding or platelets are very low, not routinely by count alone.
- DIC laboratory pattern
- Disseminated intravascular coagulation shows prolonged PT and aPTT, low fibrinogen, elevated D-dimer, and thrombocytopenia; management centers on treating the trigger, with blood products for active bleeding.
- Vitamin K deficiency bleeding
- Neonatal bleeding due to insufficient vitamin K, prevented by intramuscular vitamin K at birth; treatment uses vitamin K and fresh frozen plasma or prothrombin complex for severe hemorrhage.
- Antiphospholipid syndrome
- Thrombosis or pregnancy morbidity with persistently positive antiphospholipid antibodies; anticoagulation is indicated for thrombosis, and duration depends on provoking factors and recurrence risk.
- Acute lymphoblastic leukemia
- Most common childhood cancer, arising from lymphoid precursors; treatment includes induction, consolidation, maintenance, and central nervous system prophylaxis, with risk and minimal residual disease guiding intensity.
- Acute promyelocytic leukemia
- AML subtype with t(15;17) and PML::RARA; start all-trans retinoic acid immediately when suspected because early coagulopathy and hemorrhage are major causes of death.
- Burkitt lymphoma
- Highly proliferative B-cell lymphoma with MYC translocation; intensive chemotherapy with central nervous system prophylaxis is required, and tumor lysis syndrome prevention is critical.
- Neuroblastoma
- Sympathetic nervous system tumor of childhood with elevated urine catecholamines and MIBG avidity; MYCN amplification and age/stage determine risk and treatment intensity.
- Wilms tumor
- Childhood renal tumor often presenting as an abdominal mass; treatment combines nephrectomy and chemotherapy, with radiation for higher stages or unfavorable features.
- Retinoblastoma
- Retinal tumor presenting with leukocoria or strabismus; germline RB1 mutations increase bilateral and secondary tumor risk, and therapy preserves vision when possible.
- Tumor lysis syndrome
- Oncologic emergency with hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia; use aggressive hydration and rasburicase for high risk, avoiding rasburicase in G6PD deficiency.
- Packed red cell dose
- In children, 10–15 mL/kg of packed red cells typically raises hemoglobin by about 2 g/dL; transfuse for symptomatic anemia or defined thresholds, not a single universal hemoglobin value.
- Irradiated blood products
- Irradiation prevents transfusion-associated graft-versus-host disease by inactivating donor lymphocytes; indicated for hematopoietic stem cell transplant recipients, severe immunodeficiency, and selected intrauterine or neonatal transfusions.
- Transfusion reaction first step
- Stop the transfusion, maintain intravenous access, and assess for hemolysis, sepsis, overload, or allergic reaction; check patient and unit identification and notify the blood bank immediately.
- Acute graft-versus-host disease
- Donor lymphocytes attack recipient tissues, typically skin, gastrointestinal tract, and liver; prophylaxis uses immunosuppression, and treatment is high-dose corticosteroids with additional agents for steroid-refractory disease.
- Hematopoietic engraftment
- Neutrophil engraftment is commonly defined as an absolute neutrophil count above 500/µL for three consecutive days; platelet engraftment is sustained platelets above 20,000/µL without transfusion.
- Autologous versus allogeneic HSCT
- Autologous transplant uses the patient's own stem cells and has no graft-versus-tumor effect; allogeneic transplant uses donor cells and can produce graft-versus-tumor immunity but adds graft-versus-host disease risk.
- Febrile neutropenia
- Fever of 38.3°C once or 38.0°C sustained with severe neutropenia; obtain cultures and give empiric anti-pseudomonal antibiotics promptly, usually within 60 minutes.
- Pneumocystis prophylaxis
- Trimethoprim-sulfamethoxazole is standard prophylaxis during intensive chemotherapy or immunosuppression; alternative agents are used for sulfa allergy, and prophylaxis continues until immune recovery.
- Anthracycline cardiotoxicity
- Cumulative anthracycline exposure causes dose-dependent cardiomyopathy; monitor cardiac function by echocardiography, limit cumulative dose, and counsel survivors about later heart failure risk.
- Fertility preservation counseling
- Gonadotoxic therapy can impair future fertility; offer sperm banking, oocyte or embryo cryopreservation, and ovarian or testicular tissue options before treatment when time and age permit.
- Survivorship care plan
- A summary of cancer treatment and risks for late effects, including secondary cancers, endocrine, cardiac, and neurocognitive problems; it guides surveillance and transition to adult-focused care.
- Pediatric assent
- Children should receive developmentally appropriate information and provide assent when capable, while parents or guardians give legal consent; dissent is considered seriously in nonbeneficial research.